Navigation Links
Researchers identify key proteins needed for ovulation
Date:5/14/2009

Researchers from the National Institutes of Health and other institutions have identified in mice two proteins essential for ovulation to take place.

The finding has implications for treating infertility resulting from a failure of ovulation to occur as well as for developing new means to prevent pregnancy by preventing the release of the egg.

The proteins, called ERK1 and ERK2, appear to bring about the maturation and release of the egg.

The study, appearing in the May 15 issue of Science, was funded in part by two NIH institutes, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Cancer Institute (NCI).

"Ovulation results from a complex interplay of chemical sequences," said Duane Alexander, M.D., director of the NICHD. "The researchers have identified a crucial biochemical intermediary controlling the release of the egg. The finding advances our understanding and may one day contribute to new treatments for infertility as well as new ways to prevent pregnancy from occurring."

The study's senior author, JoAnne Richards, Ph.D., of Baylor College of Medicine, worked with Esta Sterneck and Peter Johnson, of the NCI's Center for Cancer Research; with Heng-Yu Fan and Zhilin Liu of Baylor; Masayuki Shimada, of Hiroshima University, in Japan; and Stephen Hedrick, of the University of California, San Diego.

The immature egg is contained inside a covering of cells, known as the ovarian follicle. The follicle is made largely of cells known as granulosa cells. Each month, the pituitary gland releases follicle-stimulating hormone and luteinizing hormone which cause the egg and the ovarian granulosa cells surrounding it to grow and develop into a mature follicle. Midway through the woman's monthly cycle, the pituitary releases a large surge of luteinizing hormone, which causes the follicle to rupture, releasing the egg cell. The granulosa cells in the ruptured follicle transform into luteal cells.

Previously, researchers did not know how luteinizing hormone triggered the ovary's release of the egg and the production of progesterone by the granulosa cells. In the current study, the researchers discerned that luteinizing hormone appears to signal the release of molecules known as extracellular-regulated protein kinases 1 and 2 (ERK 1 and ERK 2). In turn, these molecules trigger a chain of chemical sequences that bring about the release of the egg, the transformation of granulosa cells into luteal cells, and the production of progesterone.

ERK1 and ERK2 are a critical nexus between the surge in luteinizing hormone and ovulation, explained the NICHD project officer for the study, Louis V. De Paolo, Ph.D., chief of the NICHD Reproductive Sciences Branch.

"This a key chemical pathway that affects not only ovulation, but egg cell maturation and granulosa cell differentiation into luteal cells," Dr. De Paolo said.

Although ERK1 and ERK2 are essential intermediaries to ovulation, there are other molecules, yet to be discovered, which presumably also play important roles in the process. The Reproductive Sciences Branch is supporting studies to decipher these other intricate chemical sequences.

"We're still at the tip of the iceberg," Dr. De Paolo said. "We need to understand it all."

While understanding the function of ERK1 and ERK 2 may yield important information for treating infertility in women, this understanding might also lead to ways to prevent ovulation from occurring, for the development of new means of contraception Dr. De Paolo said.

To conduct the study, Dr. Richards and her colleagues used mice that lacked the genes needed to produce ERK1 and ERK2. The ovaries of these mice still produced eggs, but did not release them after exposure to luteinizing hormone. Moreover, the granulosa cells did not transform into luteal cells and begin producing progesterone, the normal course of events when the two genes are present.

In contrast, mice with working versions of the genes for ERK1 and ERK 2 were fertile.

To date, no other genes have been discovered that are essential to both ovulation and the conversion of the other cells to progesterone producers, according to Dr. Richards. An important role of the ERK1 and ERK2, she said, appears to be to stop the granulosa cells from growing, so that they take on their final role of producing progesterone.


'/>"/>

Contact: Robert Bock or Marianne Glass Miller
bockr@mail.nih.gov
301-496-5133
NIH/National Institute of Child Health and Human Development
Source:Eurekalert

Related medicine news :

1. Participants in antidepressant drug trials are atypical patients, UT Southwestern researchers report
2. Researchers study the human factor in spread of pandemic illness
3. Body movements can influence problem solving, researchers report
4. Researchers identify the gene responsible for a rare form of congenital anemia
5. K-State Researchers and Their Partners Making it Easier for Rural Kansans of All Ages to Stay Healthy Despite Limited Access to Facilities Like Bike Trails, Gyms
6. IBM and Medical Researchers Launch Effort To Find Flu Drug Treatments
7. Children with concussions require follow-up care before returning to play, say researchers
8. Children with Concussions Require Follow-up Care Before Returning to Play, Say Researchers
9. Cancer-obesity link discovery by MSU researchers could aid prevention efforts
10. Researchers design unique method to induce immunity to certain STDs
11. Researchers to Monitor Public Perception of Swine Flu Outbreaks Using Technology from Realtime Search Engine, OneRiot
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... 31, 2016 , ... Spectrum Aquatics has launched a brand new ADA pool ... built with the user in mind. , “Over the last two years our key ... ADA 400 lbs lift is a necessary requirement for certain facilities with specific needs,” ...
(Date:5/31/2016)... ... ... Interest is on the rise for using the CRISPR-Cas9 system for functional ... hit validation. A key reason may be that high-throughput synthesis—combined with a proprietary algorithm ... collections in arrayed formats. , Arrayed crRNA screens have the advantage ...
(Date:5/31/2016)... ... ... TeaZa® Energy, LLC announces the launch of a new limited ... . The new flavor—Tropical TeaZa? Energy—will be available to customers exclusively online starting ... flavor is best described as a juicy, taste bud takeover. A mouthwatering wave ...
(Date:5/31/2016)... ... May 31, 2016 , ... MinerEye today announced that it ... Protection report by Gartner1 Inc. , Each year, Gartner identifies new Cool Vendors ... innovative vendors and their products and services. , According to Gartner, “Gartner's Cool ...
(Date:5/31/2016)... IL (PRWEB) , ... May 31, 2016 , ... ... multichannel marketing services firm and statement solutions provider, for the tenth ... in the May 2016 issue of Advertising Age, and SourceLink ranked eighteenth in ...
Breaking Medicine News(10 mins):
(Date:5/30/2016)... , May 30, 2016 ... H1 2016" market research report with comprehensive information ... with comparative analysis at various stages, therapeutics assessment ... of administration (RoA) and molecule type, along with ... It also reviews key players involved in the ...
(Date:5/27/2016)... 2016 According to the 2016 ... driving ambulatory blood pressure monitoring system market growth. With ... ability to respond to different pressure rates, leading to ... to various cardiovascular disorders such as heart failure, stroke, ... are growing in prevalence each year. WHO estimates that ...
(Date:5/27/2016)... , May 27, 2016 The ... manufacturers, health insurance companies all falling under its umbrella.  ... companies. While not often talked about, these healthcare companies ... United States is by far the largest ... Medical Isotope Corp. (OTC: ADMD), Nutranomics Inc. (OTC: NNRX), ...
Breaking Medicine Technology: